Brief: Briacell Therapeutics Corp - Adds Additional Clinical Sites To Broaden Patient Access And Further Boost Enrollment
18/05/2022 22:51
May 18 (Reuters) - Briacell Therapeutics Corp BCT.TO :
* BRIACELL THERAPEUTICS CORP - ADDS ADDITIONAL CLINICAL
SITES TO
BROADEN PATIENT ACCESS AND FURTHER BOOST ENROLLMENT
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study